L'Oréal is doubling its stake in Galderma to 20%, capitalizing on a strong market cap increase since its initial investment.
Explore the strengths and pitfalls of EBITDA. Understand how it differs from cash flow and its role in assessing a company's ...
Investing.com -- Russian energy giant Gazprom expects its earnings before interest, taxes, depreciation, and amortization (EBITDA) to increase to 3 trillion roubles ($38 billion) in 2026, up from the ...
Earlier in December, Pinterest announced an agreement to acquire connected TV performance advertising platform tvScientific and reported rising Monthly Active Users alongside strong EBITDA and free ...
Revenue Expectations as Contracted 2026 Revenue Already Exceeds Market ConsensusNEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- ...
The simple interest formula is Interest = P * R * T. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take certain actions on our ...
Investing.com -- Moody’s Ratings has upgraded MercadoLibre, Inc. to investment grade, assigning it a Baa3 issuer rating and ...
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...
Investing.com - Italian fashion retailer OVS S.p.A. on Thursday reported strong third-quarter results with sales rising 9.0% to €452 million and adjusted EBITDA growing 9.4% to €50.6 million, driving ...
Investing.com -- S&P Global Ratings has revised its outlook on Ontex Group N.V. to stable from positive while affirming its ...
Discover how to calculate a payout ratio using Excel with our easy guide. Learn the formula and steps to evaluate dividends per share and earnings per share effectively.
Exosens shares closed at €45.35 on Dec. 18, implying a 4.1% upside to the new target. The France-based aerospace and defense components maker has a market capitalization of about €2.3 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results